Evidence map›Paper›PMID 38981683›Full record

ArticleLife science alliance2024

ER procollagen storage defect without coupled unfolded protein response drives precocious arthritis.

Kathryn M Yammine, Sophia Mirda Abularach, Seo-Yeon Kim, Agata A Bikovtseva, Jinia Lilianty, Vincent L Butty, Richard P Schiavoni, John F Bateman, Shireen R Lamandé, Matthew D Shoulders

Abstract read
In one paragraph

Article in Life science alliance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Failed Cellular Surveillance Enables Pathogenic Matrix Deposition in abioRxiv : the preprint server for biology · 2025
    Article
  2. An outcome-defining role for the triple-helical domain in regulating collagen-I assembly.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Kathryn M YammineDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID 0000-0003-4875-4103
Sophia Mirda AbularachDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.
Seo-Yeon KimDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID 0009-0004-1242-5580
Agata A BikovtsevaDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.
Jinia LiliantyMurdoch Children's Research Institute, Parkville, Australia.
Vincent L ButtyBioMicro Center, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID 0000-0003-1173-2429
Richard P SchiavoniKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
John F BatemanMurdoch Children's Research Institute, Parkville, Australia.ORCID 0000-0001-8542-0730
Shireen R LamandéMurdoch Children's Research Institute, Parkville, Australia.ORCID 0000-0003-2938-2711
Matthew D ShouldersDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA mshoulde@mit.edu.ORCID 0000-0002-6511-3431

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Jacqueline A. Lees · 1985 to 2026
$93.9M
TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI NILES, JACQUIN C · 1985 to 2020
$25.6M
Leveraging Next-Generation Directed Evolution Platforms and Chemical Control of Proteostasis to Deliver Robust Biotechnologies and Illuminate Roles of Chaperone Networks in Protein EvolutionR35GM136354 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SHOULDERS, MATTHEW DONALD · 2020 to 2024
$2.1M
Defining and Modulating Mechanisms of Collagen ProteostasisR01AR071443 · NIAMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SHOULDERS, MATTHEW DONALD · 2017 to 2021
$1.7M
Chondronoids for Studying Collagen-II Homeostasis and DiseasesF31AR079263 · NIAMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI YAMMINE, KATHRYN · 2021 to 2023
$140k
Medical Research CouncilNCI NIH HHS P30 CA014051NIAMS NIH HHS F31 AR079263NIAMS NIH HHS R01 AR071443NIEHS NIH HHS P30 ES002109NIGMS NIH HHS R35 GM136354
6 · The paper itself

Abstract

Collagenopathies are a group of clinically diverse disorders caused by defects in collagen folding and secretion. For example, mutations in the gene encoding collagen type-II, the primary collagen in cartilage, can lead to diverse chondrodysplasias. One example is the Gly1170Ser substitution in procollagen-II, which causes precocious osteoarthritis. Here, we biochemically and mechanistically characterize an induced pluripotent stem cell-based cartilage model of this disease, including both hetero- and homozygous genotypes. We show that Gly1170Ser procollagen-II is notably slow to fold and secrete. Instead, procollagen-II accumulates intracellularly, consistent with an endoplasmic reticulum (ER) storage disorder. Likely owing to the unique features of the collagen triple helix, this accumulation is not recognized by the unfolded protein response. Gly1170Ser procollagen-II interacts to a greater extent than wild-type with specific ER proteostasis network components, consistent with its slow folding. These findings provide mechanistic elucidation into the etiology of this disease. Moreover, the easily expandable cartilage model will enable rapid testing of therapeutic strategies to restore proteostasis in the collagenopathies.

Indexed as

Collagen Type IIEndoplasmic ReticulumProcollagenUnfolded Protein ResponseAnimalsArthritisCartilageChondrocytesHumansInduced Pluripotent Stem CellsMutationOsteoarthritisProtein FoldingCollagen Type IIProcollagen

Identifiers

PMID38981683
PMCPMC11234256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.